Dr. Reichel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
260 Tremont Street
Bwd 10
Boston, MA 02116Phone+1 617-636-1648Fax+1 617-636-4866
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1989 - 1992
- Massachusetts General HospitalInternship, Internal Medicine, 1986 - 1987
- Albert Einstein College of MedicineClass of 1986
Certifications & Licensure
- MA State Medical License 1992 - 2025
- FL State Medical License 2012 - 2018
- ME State Medical License Active through 2000
- RI State Medical License 1996 - 1999
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Eplerenone for Central Serous Chorioretinopathy Start of enrollment: 2013 May 01
- Treatment of Macular Edema After Cataract Surgery With Subconjunctival Aflibercept Start of enrollment: 2019 Feb 22
Publications & Presentations
PubMed
- Pseudoaveraging for denoising of OCT angiography: a deep learning approach for image quality enhancement in healthy and diabetic eyes.Omar Abu-Qamar, Warren Lewis, Luisa S M Mendonca, Luis De Sisternes, Adam Chin
International Journal of Retina and Vitreous. 2023-10-11 - Ocular phenotype in a patient withgene mutation-associated papillorenal syndrome.Christine L Benador-Shen, Elias Reichel, Dallas Reed, Lawrence S Milner, Nancy Pinnell
Ophthalmic Genetics. 2022-06-01 - Variants of Uncertain Significance: Twins With Identical Pathogenic Gene Mutations in Retinitis Punctata Albescens.Alyse J Richard, Rachel M. Huckfeldt, Elias Reichel, Michelle C. Liang
Ophthalmic Surgery, Lasers & Imaging Retina. 2021-08-01
Press Mentions
- Market Cap of EyePoint Pharmaceuticals Inc. [EYPT] Reaches 65.23M – Now What?November 27th, 2020
- EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4November 19th, 2020
- Citation: Versek C, Banijamali SMA, Bex PJ, Lashkari J, Kamarthi SC, Sridhar S (2020) Portable Objective Diagnostics Using Visual Evoked Potentials for Age-Related Macular Degeneration. J Clin Exp Ophthalmol. 11:863November 2nd, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: